Submitted by Anonymous (not verified) on 25 October 2023 - 10:42
Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Multiple Myeloma, Date of authorisation: 25/08/2020, Revision: 7, Status: Authorised
Source: